Moderna is a biotechnology business based in the US. Moderna stocks (MRNA.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $142.85 – an increase of 3.94% over the previous week. Moderna employs 3,200 staff and has a trailing 12-month revenue of around $22.6 billion.
How to buy stocks in Moderna
- Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – MRNA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Moderna?
- Has coronavirus impacted Moderna shares?
- Moderna shares summary
- Compare share dealing platforms
- Is Moderna stock a buy or sell?
- Moderna performance over time
- Are Moderna shares over-valued?
- Moderna's financials
- How volatile are Moderna shares?
- Does Moderna pay a dividend?
- Other common questions
Moderna stock price (NASDAQ:MRNA)Use our graph to track the performance of MRNA stocks over time.
Moderna shares at a glance
|Latest market close||$149.95|
|52-week range||$115.61 - $497.49|
|50-day moving average||$139.19|
|200-day moving average||$219.63|
|Wall St. target price||$219.33|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$34.02|
Compare stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Moderna stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Moderna price performance over time
|1 week (2022-06-27)||3.16%|
|1 month (2022-06-01)||4.57%|
|3 months (2022-03-31)||-12.95%|
|6 months (2021-12-31)||-40.96%|
|1 year (2021-07-02)||-36.00%|
|2 years (2020-07-02)||156.02%|
|3 years (2019-07-03)||879.43%|
|5 years (2017-06-30)||N/A|
Is Moderna under- or over-valued?
Valuing Moderna stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Moderna's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Moderna's P/E ratio
Moderna's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 4x. In other words, Moderna shares trade at around 4x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Moderna's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $16.6 billion.
The EBITDA is a measure of a Moderna's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$22.6 billion|
|Operating margin TTM||71.93%|
|Gross profit TTM||$13.9 billion|
|Return on assets TTM||50.42%|
|Return on equity TTM||139.99%|
|Market capitalisation||$57.8 billion|
TTM: trailing 12 months
Moderna share dividends
We're not expecting Moderna to pay a dividend over the next 12 months.
Moderna share price volatility
Over the last 12 months, Moderna's shares have ranged in value from as little as $115.61 up to $497.49. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Moderna's is 1.6928. This would suggest that Moderna's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Moderna, Inc. , a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co. , Inc. ; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.
Stocks similar to Moderna
Moderna in the news
How mRNA tech blew open the door of UPS's cold chain logistics business
FDA Recommends Adding New Omicron Subvariants to COVID Boosters
The U.S. bets billions of dollars on better COVID-19 boosters as it prepares for a spike in COVID-19 cases next winter
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
Here are the best Canadian investment newsletters to help you boost your investment knowledge and grow your wealth.Read more…
Here are some investment ideas that could do well despite rising interest rates.Read more…
iGaming is now legal in Ontario. Find out which companies to keep an eye on with our list of 10 top online gaming stocks.Read more…
More guides on Finder
Find the best investment newsletters in Canada
Here are the best Canadian investment newsletters to help you boost your investment knowledge and grow your wealth.
How to buy Onfolio Holdings (ONFO) stock in Canada when it goes public
Everything we know about the Onfolio Holdings IPO plus information on how to buy in.
How to buy Acadian Timber stock in Canada
Steps to owning and managing ADN stock, with 24-hour and historical pricing before you buy.
How to buy Mobilicom Limited (MOB) stock in Canada
Everything we know about the Mobilicom Limited IPO plus information on how to buy in.
How to buy Consumer Staples Select Sector SPDR Fund stock in Canada
Steps to owning and managing XLP stock, with 24-hour and historical pricing before you buy.
How to buy Schwab U.S. REIT ETF stock in Canada
Steps to owning and managing SCHH stock, with 24-hour and historical pricing before you buy.
How to buy iShares US Consumer Staples ETF stock in Canada
Steps to owning and managing IYK stock, with 24-hour and historical pricing before you buy.
How to buy Vanguard Real Estate Index Fund ETF Shares stock in Canada
Steps to owning and managing VNQ stock, with 24-hour and historical pricing before you buy.
How to buy SPDR S&P Insurance ETF stock in Canada
Steps to owning and managing KIE stock, with 24-hour and historical pricing before you buy.
How to buy Financial Select Sector SPDR Fund stock in Canada
Steps to owning and managing XLF stock, with 24-hour and historical pricing before you buy.